Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Chicago
Study ID
NCT06446661
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
15 Years - 39 Years
Healthy Volunteers
Not accepted

Interventions

  • High Intensity — OTHER
    Daily texts
  • No Text Messagings — OTHER
    Standard Care
  • Low Intensity Text Messaging — OTHER
    Weekly Texts

Study Details

The purpose of this section is to learn how text message reminders might help with regularly taking chemotherapy medications for Adolescents and Adults with Acute Lymphoblastic leukemia (ALL).

Key Dates

Start date
Dec 15, 2026
Status verified
Mar 2026
Primary completion
Jun 15, 2027
Completion
Jun 15, 2028

Study Design

Enrollment
38 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Active Comparator: High Intensity
    Receives high-intensity text messaging for 2 cycles of treatment
  • Active Comparator: Low Intensity
    Receives no texts for 1st cycle and low-intensity texts for 2nd cycle

Primary Outcome Measure

To compare adherence to oral chemotherapy with mercaptopurine and methotrexate [ Time Frame: 84 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Chicago Medicine Comprehensive Cancer CenterChicagoIllinois60637
Clinical Trials Intake
[email protected]
855-702-8222
Wendy Stock (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chicago, IL

By condition
Leukemia (other)
By specialty
OncologyBlood cancer
By research site
University of Chicago Medicine Comprehensive Cancer Center· Chicago, IL

Related Studies